Literature DB >> 11779295

Blastic natural killer cell leukemia/lymphoma presenting as overt leukemia.

A Alvarez-Larrán1, N Villamor, J C Hernández-Boluda, A Ferrer, M Camós, E Campo, A López-Guillermo.   

Abstract

Blastic natural killer (NK)-cell leukemia/lymphoma is a neoplasm of NK origin with aggressive behavior. The disease affects mainly elderly people and often presents with skin lesions and overt leukemia. Blastic morphology, an NK-cell immunophenotype, and lack of association with Epstein-Barr virus are the clues for the diagnosis. We report herein, the case of a patient with a blastic NK-cell leukemia/lymphoma with overt leukemia at diagnosis, who achieved a complete response after CHOP (cyclophosphamide/doxorubicin/vincristine/prednisone) chemotherapy. However, the patient relapsed a few months later and died due to disease progression. Cases of blastic NK-cell leukemia/ lymphoma previously reported are briefly reviewed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11779295     DOI: 10.3816/clm.2001.n.024

Source DB:  PubMed          Journal:  Clin Lymphoma        ISSN: 1526-9655


  2 in total

1.  Uncommon cases of immature-type CD56+ natural killer (NK)-cell neoplasms, characterized by expression of myeloid antigen of blastic NK-cell lymphoma.

Authors:  Satsuki Owatari; Maki Otsuka; Taketsugu Takeshita; Kyoko Mizukami; Sinsuke Suzuki; Kimiharu Uozumi; Yukie Tashiro; Naomichi Arima; Shuichi Hanada
Journal:  Int J Hematol       Date:  2008-12-25       Impact factor: 2.490

Review 2.  What is CD4+CD56+ malignancy and how should it be treated?

Authors:  P Reimer; T Rüdiger; D Kraemer; V Kunzmann; F Weissinger; A Zettl; H Konrad Müller-Hermelink; M Wilhelm
Journal:  Bone Marrow Transplant       Date:  2003-10       Impact factor: 5.483

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.